ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sprycel combo gets FDA approval
January 04, 2019The US Food and Drug Administration has approved a new treatment for children one year of age and older, facing a type of blood cancer known as Philadelphia chromosome-positive (Ph+) acute lymphoblastic -
New treatment for adults with relapsed or refractory acute lymphoblastic leukemia
August 21, 2017Besponsa is a targeted therapy that is thought to work by binding to B-cell ALL cancer cells that express the CD22 antigen, blocking the growth of cancerous cells.
Pharma Sources Insight January 2025
